Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Osteoporosis 2Breast Neoplasms 2Polycystic Ovary Syndrome 1Myocardial Ischemia 1Infertility, Female 1Heart Diseases 1Fractures, Bone 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Bone Diseases 1

Interventions

Surveys and Questionnaires 2ulipristal acetate 1follitropin beta 1follicle stimulating hormone, human, with HCG C-terminal peptide 1cetrorelix 1Triptorelin Pamoate 1Solutions 1Oocyte Retrieval 1Nitroglycerin 1Metformin 1Menotropins 1Liraglutide 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Intravital Microscopy 1Inositol 1Injections 1Hormone Replacement Therapy 1Gonadotropins 1Folic Acid 1Desogestrel 1Contraceptives, Oral 1Chorionic Gonadotropin 1Blood Specimen Collection 1Acetylcarnitine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Infertility, Female × Hormone Replacement Therapy × Clear all
NCT05189873 2022-01-13

GnRH Agonist Plus Hormone Replacement Therapy vs Hormone Replacement Therapy on IVF Outcomes

Tehran University of Medical Sciences

Phase 3 Completed
128 enrolled

Infertility, Female, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡